Movement Alert|Semtech Rises 5.3% in Regular Trading, Multiple Analyst Upgrades Signal Strong Upside Potential

Market Focus
Sep 26

On September 26, Semtech rose 5.3% in regular trading, trading at 183.9 USD/share, with turnover of $224 million. The rally was driven by a wave of bullish analyst coverage highlighting the company's growth trajectory.

On the news front, Seaport recently initiated coverage of Semtech with a Buy rating and a $200 price target. Meanwhile, UBS raised its price target to $230 from $225 while maintaining a Buy rating, citing expectations that data center revenue could reach a $200 million quarterly run-rate by fiscal Q1 2028. The current analyst consensus target stands at approximately $209, implying meaningful upside from the current price level.

The optimism is underpinned by strong fundamentals. Semtech reported fiscal Q2 adjusted EPS of $0.71, beating the $0.57 consensus estimate by nearly 25%, while revenue of $341.9 million also topped expectations. Q3 revenue guidance of $405-$415 million significantly exceeded pre-earnings estimates. Additionally, the company's strategic divestiture of its cellular module business to Compal Electronics for $62 million is expected to improve gross margins by approximately 500 basis points, further sharpening its focus on high-growth data center and AI infrastructure markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10